ImpriMed said CEO Dr. Sungwon Lim will speak at the NCI functional precision medicine workshop, highlighting the company’s positioning in the functional precision medicine space. The update is informational with no reported financial results, guidance, or material operational change.
ImpriMed said CEO Dr. Sungwon Lim will speak at the NCI functional precision medicine workshop, highlighting the company’s positioning in the functional precision medicine space. The update is informational with no reported financial results, guidance, or material operational change.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
